在接受化疗的癌症患者体力康复的技术资源:一个范围审查
Anabela Amarelo1,2, Marisa Mota1, Bruno Amarelo1
1Gaia-Espinho Local Health Unit, 4434-502 Vila Nova de Gaia, Portugal.
Cancers
|December 17, 2024
概括
像可穿戴设备和应用程序这样的技术工具有助于癌症患者在物理康复中接受化疗. 需要进一步的研究来确认这些数字健康干预措施的长期益处和整合.
科学领域:
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
- 数字健康数字健康
背景情况:
- 化疗显著损害癌症患者的身体功能和生活质量.
- 技术资源为这群人提供了新的身体康复途径.
- 化学疗法相关的身体康复中技术应用的范围需要探索.
研究的目的:
- 进行范围审查,绘制化学治疗癌症患者身体康复的技术工具.
- 在此背景下识别和分类使用的数字健康干预措施.
- 探索这些技术在改善患者结果和护理方面的潜力.
主要方法:
- 范围审查遵循乔安娜·布里格斯研究所 (JBI) 的指导方针和PRISMA-ScR框架.
- 在 MEDLINE,CINAHL,Scopus,SPORTDiscus 和 COCHRANE 数据库中进行搜索.
- 使用世界卫生组织的"数字健康干预分类v1.0"进行干预的分类.
主要成果:
- 包括32项使用各种技术的研究.
- 主导技术:可穿戴设备 (16项研究),网络/远程康复 (7),移动健康 (6),虚拟现实 (2) 和游戏 (3).
- 旨在增强身体功能,管理症状和改善生活质量的技术,可穿戴设备在活动监控和网络/mHealth在远程参与方面表现出色.
结论:
- 技术资源为化疗患者的个性化康复提供了巨大的潜力.
- 进一步的研究对于评估长期有效性,成本效益和临床整合至关重要.
- 数字康复工具的更广泛的可访问性和可持续影响需要继续进行调查.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


